Manulife (Manufacturers Life Insurance)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Buy
91,034
+272
+0.3% +$52.8K 0.02% 637
2025
Q4
$15.8M Sell
90,762
-36,695
-29% -$6.68M 0.01% 708
2025
Q3
$24.3M Sell
127,457
-92,628
-42% -$16.4M 0.02% 586
2025
Q2
$39.5M Sell
220,085
-5,119
-2% -$889K 0.04% 423
2025
Q1
$38.1M Sell
225,204
-777
-0.3% -$128K 0.04% 419
2024
Q4
$34.1M Buy
225,981
+54,287
+32% +$8.44M 0.03% 470
2024
Q3
$26.7M Buy
171,694
+45,577
+36% +$6.81M 0.02% 541
2024
Q2
$17.3M Buy
126,117
+1,053
+0.8% +$144K 0.02% 653
2024
Q1
$16.6M Sell
125,064
-10,084
-7% -$1.31M 0.02% 676
2023
Q4
$18.6M Buy
135,148
+7,415
+6% +$975K 0.01% 644
2023
Q3
$15.6M Buy
127,733
+1,981
+2% +$264K 0.01% 656
2023
Q2
$17.7M Buy
125,752
+8,659
+7% +$1.19M 0.01% 632
2023
Q1
$16.6M Sell
117,093
-4,425
-4% -$633K 0.01% 654
2022
Q4
$19M Buy
121,518
+1,351
+1% +$194K 0.01% 593
2022
Q3
$14.8M Buy
120,167
+3,866
+3% +$509K 0.01% 678
2022
Q2
$15.6M Sell
116,301
-8,450
-7% -$1.15M 0.01% 679
2022
Q1
$17.1M Buy
124,751
+30,586
+32% +$4.26M 0.01% 706
2021
Q4
$16.3K Sell
94,165
-20,352
-18% -$3.1M 0.01% 733
2021
Q3
$16.6M Sell
114,517
-16,025
-12% -$2.34M 0.01% 734
2021
Q2
$17.2M Sell
130,542
-2,376
-2% -$311K 0.01% 729
2021
Q1
$17.1M Sell
132,918
-422
-0.3% -$52K 0.01% 716
2020
Q4
$15.9M Sell
133,340
-8,367
-6% -$1.02M 0.01% 688
2020
Q3
$16.2M Sell
141,707
-1,448
-1% -$171K 0.02% 609
2020
Q2
$15.8M Sell
143,155
-3,146
-2% -$334K 0.01% 606
2020
Q1
$11.7M Buy
146,301
+19,949
+16% +$2.07M 0.01% 670
2019
Q4
$13.5M Sell
126,352
-7,041
-5% -$734K 0.01% 688
2019
Q3
$14.1M Buy
133,393
+10,250
+8% +$1.05M 0.02% 668
2019
Q2
$12.5M Sell
123,143
-10,256
-8% -$986K 0.01% 721
2019
Q1
$12M Sell
133,399
-1,158
-0.9% -$100K 0.01% 768
2018
Q4
$11.2M Sell
134,557
-3,166
-2% -$297K 0.01% 721
2018
Q3
$14.9M Sell
137,723
-18,660
-12% -$2.05M 0.02% 694
2018
Q2
$17.2M Buy
156,383
+11,545
+8% +$1.2M 0.02% 639
2018
Q1
$14.5M Buy
144,838
+3,061
+2% +$314K 0.02% 702
2017
Q4
$14M Sell
141,777
-5,175
-4% -$491K 0.02% 706
2017
Q3
$13.8M Buy
146,952
+6,203
+4% +$659K 0.02% 678
2017
Q2
$15.6M Sell
140,749
-33,142
-19% -$3.5M 0.02% 637
2017
Q1
$17.1M Buy
173,891
+36,197
+26% +$3.45M 0.02% 595
2016
Q4
$12.7M Buy
137,694
+702
+0.5% +$60.5K 0.02% 627
2016
Q3
$11.6M Sell
136,992
-3,774
-3% -$317K 0.02% 640
2016
Q2
$11.5M Sell
140,766
-3,257
-2% -$248K 0.02% 626
2016
Q1
$10.4M Buy
144,023
+2,392
+2% +$160K 0.01% 653
2015
Q4
$10.1K Sell
141,631
-20,781
-13% -$1.4M 0.01% 661
2015
Q3
$9.98K Sell
162,412
-16,193
-9% -$1.13M 0.01% 665
2015
Q2
$13K Sell
178,605
-349,877
-66% -$25.8M 0.02% 567
2015
Q1
$40.6K Sell
528,482
-1,419,379
-73% -$102M 0.05% 263
2014
Q4
$131K Buy
1,947,861
+17,649
+0.9% +$1.11M 0.19% 110
2014
Q3
$117K Sell
1,930,212
-882,490
-31% -$54.4M 0.17% 109
2014
Q2
$165M Sell
2,812,702
-989,990
-26% -$58M 0.25% 82
2014
Q1
$220K Buy
3,802,692
+3,660,938
+2,583% +$196M 0.35% 59
2013
Q4
$7.59K Sell
141,754
-278,816
-66% -$16.5M 0.01% 783
2013
Q3
$26K Buy
420,570
+49,352
+13% +$2.95M 0.04% 339
2013
Q2
$22.5M Buy
+371,218
New +$22.1M 0.04% 342

Other funds holding DGX

Manulife (Manufacturers Life Insurance)'s DGX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Quest Diagnostics (DGX) stake by 0.3% in Q1 2026, buying an estimated $52.8K and bringing the position to 91,034 shares worth $17.8M. The position accounts for 0.02% of the portfolio, ranked #637.

Manulife (Manufacturers Life Insurance) first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $165M in Q2 2014. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 91,034 shares of Quest Diagnostics worth $17.8M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 272 Quest Diagnostics shares in Q1 2026, an estimated $52.8K.
  • Quest Diagnostics made up 0.02% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #637 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Quest Diagnostics position peaked at $165M in Q2 2014.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.